We are live on
!
Find out more
VCAM
Valentine Capital Asset Management Portfolio holdings
AUM
$89.6M
1-Year Est. Return
0.84%
This Fund
S&P 500
This Quarter
Est. Return
+6.31%
1 Year Est. Return
-0.84%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$411M
AUM Growth
+$152M
(+59%)
Cap. Flow
+$147M
Cap. Flow
% of AUM
35.63%
Top 10 Holdings %
Top 10 Hldgs %
25.23%
Holding
112
New
51
Increased
9
Reduced
38
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$9.43M |
| 2 |
AGN
Allergan plc
AGN
|
+$8.89M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$8.82M |
| 4 |
Omega Healthcare
OHI
|
+$8.36M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$7.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hawaiian Electric Industries
HE
|
+$10.4M |
| 2 |
TARO
Taro Pharmaceutical Industries Ltd.
TARO
|
+$5.72M |
| 3 |
Chevron
CVX
|
+$5.67M |
| 4 |
Magna International
MGA
|
+$5.46M |
| 5 |
RPM International
RPM
|
+$5.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.33% |
| 2 | Consumer Discretionary | 10.87% |
| 3 | Technology | 7.98% |
| 4 | Energy | 6.94% |
| 5 | Communication Services | 6.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ETW
101
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.06B
| – | – |
-340,678
| Closed | -$4.14M |
|
102
Gilead Sciences
GILD
$165B
| – | – |
-3,000
| Closed | -$319K |
|
103
Generac Holdings
GNRC
$12.2B
| – | – |
-9,100
| Closed | -$369K |
|
|
104
Hawaiian Electric Industries
HE
$2.02B
| – | – |
-391,549
| Closed | -$10.4M |
|
105
JPMorgan Chase
JPM
$956B
| – | – |
-5,475
| Closed | -$330K |
|
106
Keurig Dr Pepper
KDP
$39.9B
| – | – |
-6,567
| Closed | -$422K |
|
107
Marathon Petroleum
MPC
$90B
| – | – |
-8,982
| Closed | -$380K |
|
|
NFJ
108
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.44B
| – | – |
-28,950
| Closed | -$529K |
|
|
NVO
109
Novo Nordisk
NVO
$209B
| – | – |
-204,576
| Closed | -$4.87M |
|
110
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$794M
| – | – |
-16,600
| Closed | -$214K |
|
111
Direxion Daily Technology Bull 3x ETF
TECL
$6.05B
| – | – |
-1,090,200
| Closed | -$2.75M |
|
|
GNC
112
DELISTED
GNC Holdings, Inc.
GNC
| – | – |
-115,354
| Closed | -$4.47M |
|
Similar funds
TSBJ
TP
SPC
DA
KCA
CCM
ST
HCM
Valentine Capital Asset Management's Q4 2014 Portfolio in Review
As of Q4 2014, Valentine Capital Asset Management held 112 positions worth $411M, up 59% from $259M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Valentine Capital Asset Management deployed $147M of net new capital in Q4 2014, opening 51 new positions and adding to 9 existing holdings. Its largest new stake was Jazz Pharmaceuticals: 56,827 shares worth $9.3M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Taro Pharmaceutical Industries Ltd., an estimated $5.72M trimmed.
- Valentine Capital Asset Management's largest Q4 2014 buy was Jazz Pharmaceuticals: 56,827 shares worth $9.3M.
- Valentine Capital Asset Management added most to Under Armour in Q4 2014, an estimated $3.81M increase.
- Valentine Capital Asset Management's biggest Q4 2014 reduction was Taro Pharmaceutical Industries Ltd., cutting an estimated $5.72M.
- Valentine Capital Asset Management fully exited Hawaiian Electric Industries in Q4 2014, selling an estimated $10.4M.
- Valentine Capital Asset Management's ten largest holdings make up 25% of its $411M portfolio in Q4 2014.
- Valentine Capital Asset Management opened 51 new positions and closed 14 in Q4 2014.
- Valentine Capital Asset Management's portfolio value rose 59% quarter-over-quarter to $411M.
Based on Valentine Capital Asset Management's 13F filing for Q4 2014, filed 12 Feb 2015.